Jonathan H. Kaufman - 13 Mar 2025 SCHEDULE 13D/A Report for Lipella Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (LIPO)

Filing Manager: Jonathan H. Kaufman
Reporting Manager: Jonathan H. Kaufman
Security: Lipella Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: LIPO
Shares outstanding: 2,653,613 shares
Disclosed Ownership: 212,289 shares
Ownership: 8%
Form type: SCHEDULE 13D/A
Filing time: 17 Mar 2025, 20:18:13 UTC
Date of event: 13 Mar 2025
Previous filing: 11 Mar 2025
Next filing: 19 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Jonathan H. Kaufman	8%	212,289	212,289	0	/s/ Jonathan H. Kaufman	Jonathan H. Kaufman	0001959250